<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We have recently found that the median relative risk value (RRV) (0-1) of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> estimated by protein-conjugated <z:chebi fb="2" ids="15368">acrolein</z:chebi> (PC-Acro), IL-6 and CRP together with age was in the order silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (SBI) (0.80)&gt;carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (CA) (0.76)&gt;white matter hyperintensity (WMH) (0.46)&gt;control (0.14) </plain></SENT>
<SENT sid="1" pm="."><plain>We clarified how <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> [<z:hpo ids='HP_0000822'>hypertension</z:hpo> (HT), <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) and <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (HG)] are correlated with RRV </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The levels of PC-Acro, IL-6 and CRP in plasma were measured by ELISA </plain></SENT>
<SENT sid="3" pm="."><plain>SBI and WMH were evaluated by MRI, and CA was evaluated by duplex carotid ultrasonography </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The median RRV of <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> was in the order HT+HG (0.84)&gt;HT+<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> (0.73)&gt;HT (0.65)≈HG (0.65)&gt;<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> (0.61)&gt;<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>+HG (0.48)&gt;no <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> (0.24)&gt;<z:mpath ids='MPATH_458'>normal</z:mpath> (0.11) </plain></SENT>
<SENT sid="5" pm="."><plain>Correlation with SBI was in the order HT+HG (52%)&gt;HT+<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> (42%)&gt;HT (40%)&gt;HG (34%)≈<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>(33%)&gt;<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>+HG (14%)≈no <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> (14%) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The results indicate that HT is the most strongly associated factor with SBI among <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> and that the seriousness of <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> estimated by RRV was well correlated with SBI </plain></SENT>
</text></document>